Monoamine oxidase inhibitors in rheumatoid arthritis - anti-tumor necrosis factor?

By Altschuler E.L.  

International Journal of Immunopharmacology, Vol. 22, Iss. 11, 2000-11 ,pp. : 1007-1008

Elsevier

Access to resources Recommend Favorite

Systematic Review of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis

By Cordero-Coma Miguel  

Ocular Immunology and Inflammation, Vol. 21, Iss. 1, 2013-02 ,pp. : 12-20

Informa Healthcare

Access to resources Recommend Favorite

Neurochemical sensitization associated with systemic administration of tumor necrosis factor- : adjuvant action in combination with bovine serum albumin

By Anisman H.   Turrin N.P.   Merali Z.   Hayley S.  

Journal of Neuroimmunology, Vol. 145, Iss. 1, 2003-12 ,pp. : 91-102

Elsevier

Access to resources Recommend Favorite

Modification of tumor necrosis factor-induced acute toxicity d-galactosamine challenge by polymyxin B, an anti-endotoxin

By Sakaguchi S.   Furusawa S.   Yokota K.   Takayanagi M.   Takayanagi Y.  

International Journal of Immunopharmacology, Vol. 22, Iss. 11, 2000-11 ,pp. : 935-942

Elsevier

Access to resources Recommend Favorite

In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors

By Punzon C.   Alcaide A.   Fresno M.  

International Immunopharmacology, Vol. 3, Iss. 9, 2003-09 ,pp. : 1293-1299

Elsevier

Access to resources Recommend Favorite